Pharmaceutical Executive July 7, 2025
Mike Hollan

The AI company’s tech will be integrated with Microsoft Azure’s infrastructure.

Healthcare and technology companies continue to partner to bring AI into the pharma landscape. Many people believe that the machine learning algorithms have the potential to change the way many processes are performed in the healthcare space. This includes everything from drug development, marketing, and even diagnosing.

How is AI being used in cancer diagnosis?

Lunit and Microsoft are working together to push for the use of AI in cancer diagnosis.1 The companies will provide greater access to AI-powered tools through Microsoft Azure’s global cloud infrastructure.

This includes both companies working together to provide cloud users with customizable AI models while also leveraging the platform to incorporate AI...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma, Pharma / Biotech, Technology, Trends
AI-enabled clinical data abstraction: a nurse’s perspective
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
OpenAI’s latest product lets you vibe code science
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs

Share Article